Position in SVRA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$616,000
New position
Shares Held
100,000
first reported quarter
Ownership
0.049%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#76
of 181 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026DCF Advisers, LLC holds $72,469,035 across 22 Biotechnology names. SVRA ranks #18 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
14,200 | $13,174,334 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
637,500 | $9,524,250 | |
| 3 | HELP |
Cybin Inc.
|
1,434,988 | $9,485,270 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,250 | $5,767,745 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,500 | $5,712,395 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
141,000 | $4,778,490 | |
| 7 | INCY |
Incyte Corp
|
41,500 | $4,704,440 | |
| 8 | IMRX |
Immuneering Corp
|
790,000 | $3,942,100 |
All Filings in SVRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $616,000 | 100,000 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||